Menu Back toRight the First Time: Integrating Diagnostic Strategies into Clinical Development Plans

DIA 2021 Global Annual Meeting

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans

Session Chair(s)

Earl Seltzer, MBA

Earl Seltzer, MBA

  • Senior Director, Feasibility and Site Selection
  • Labcorp Drug Development, United States
Having a product approved does not guarantee uptake post approval. This session will provide recommendations to insert evidence generating diagnostic strategies earlier in clinical development and will discuss case studies on different tactics.
Learning Objective : Identify areas of opportunity to insert diagnostic strategies to generate real-world evidence into clinical development plans; Assess existing clinical development plans for new therapeutics and integrate evidence collection to support post approval product uptake.

Speaker(s)

Patrick Short

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans

Patrick Short

  • Chief Executive Officer
  • Sano Genetics, United Kingdom
Keith Hanigan

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans

Keith Hanigan

  • US Head of Precision Medicine
  • Blueprint Medicines , United States
Jeffrey Shuster, PhD

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans

Jeffrey Shuster, PhD

  • Director, Companion Diagnostics
  • Covance Central Laboratory Services, United States